Immune Neoadjuvant Therapy Study of Durvalumab in Early Stage Non-small Cell Lung Cancer
Clinical trial NCT03030131 · TERMINATED
Trial details
- NCT number
- NCT03030131
- Sponsor
- Intergroupe Francophone de Cancerologie Thoracique
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-12
- Primary completion
- 2019-08-28
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.